An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma.

Zhou, Xuan; He, Ying-Zhi; Liu, Dan; Lin, Chao-Ran; Liang, Dan; Huang, Rui; Wang, Liang

Zhou, Xuan; He, Ying-Zhi; Liu, Dan; Lin, Chao-Ran; Liang, Dan; Huang, Rui; Wang, Liang.

Afiliación

Zhou X; Second Clinical Medical College of Southern Medical University, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
He YZ; Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Liu D; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Lin CR; The First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, China.
Liang D; The First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, China.
Huang R; Second Clinical Medical College of Southern Medical University, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Wang L; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.

Front Genet ; 13: 862179, 2022.

Article en En | MEDLINE | ID: mdl-35846146

Palabras clave

autophagy inhibitors; autophagy-related genes; diffuse large B-cell lymphoma; gene signature; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Genet Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google